Literature DB >> 1519869

NHLBI workshop summary. Biology of lung preservation for transplantation.

J D Cooper1, C E Vreim.   

Abstract

The types of animal models that are used for assessing lung preservation, and the types of interventions that are likely to prove of value, must be carefully selected. For example, the events of warm ischemia are not necessarily the same as those that occur during cold preservation. Warm ischemia has often been used as a means of accelerating the degree of ischemic injury, but the events may not be qualitatively the same. Nonetheless, the use of different types of lung injury models contributes to our overall understanding of mechanisms of lung injury associated with transplantation. Pathologic studies of lung injury ischemia and reperfusion may not prove helpful, as they may be nonspecific and insensitive. To compare results of different preservation methods, a standardized animal model would be most helpful if a universally accepted one could be identified. This would include standard measurements of lung function, standard techniques of transplantation, and follow-up studies of several days' duration after transplantation. Such a model could serve as the ultimate test of preservation methods following its development in a variety of the animal models. It must be emphasized that whereas animal models generally begin with a normal lung that is preserved, the clinical situation differs because the donor lungs may be far from normal at the outset due to the effects of brain death, hemodynamic instability, infection, trauma, and a host of other factors. Thus, the limits of safe preservation in a clinical situation may well be significantly less than the safe preservation time demonstrated in the laboratory.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1519869     DOI: 10.1164/ajrccm/146.3.803

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  6 in total

1.  Functional and biochemical evaluation of the preserved lung in a rat model.

Authors:  T Hanagiri; H Igisu; H Matsumura; K Yasumoto
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

2.  Lung transplantation: a decade of experience.

Authors:  B F Meyers; J Lynch; E P Trulock; T J Guthrie; J D Cooper; G A Patterson
Journal:  Ann Surg       Date:  1999-09       Impact factor: 12.969

3.  Cell death in human lung transplantation: apoptosis induction in human lungs during ischemia and after transplantation.

Authors:  S Fischer; S D Cassivi; A M Xavier; J A Cardella; E Cutz; V Edwards; M Liu; S Keshavjee
Journal:  Ann Surg       Date:  2000-03       Impact factor: 12.969

4.  Effects of ischaemia and preservation on the ultrastructure of the bronchiolar epithelium. A quantitative electron microscopic study of human and canine lungs.

Authors:  N Stolte; H Fehrenbach; M Ochs; A Schmiedl; S W Hirt; T Wahlers; J Richter
Journal:  Virchows Arch       Date:  1996-10       Impact factor: 4.064

5.  Experimental chronic kidney disease attenuates ischemia-reperfusion injury in an ex vivo rat lung model.

Authors:  Chung-Kan Peng; Kun-Lun Huang; Chou-Chin Lan; Yu-Juei Hsu; Geng-Chin Wu; Chia-Hui Peng; Chin-Pyng Wu; Khee-Siang Chan
Journal:  PLoS One       Date:  2017-03-14       Impact factor: 3.240

6.  Mesenchymal Stem Cell Therapy Facilitates Donor Lung Preservation by Reducing Oxidative Damage during Ischemia.

Authors:  Natalia Pacienza; Diego Santa-Cruz; Ricardo Malvicini; Oscar Robledo; Gastón Lemus-Larralde; Alejandro Bertolotti; Martín Marcos; Gustavo Yannarelli
Journal:  Stem Cells Int       Date:  2019-08-05       Impact factor: 5.443

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.